Rosso et al. [20] reported that biopsy-proven NAFLD serum sCD163 levels were associated with circulating free fatty acids (FFAs), lipid flux, adipose tissue IR as well as with changes in lipid metabolism such as FFA overflow and activating macrophages in the liver. Here, CD163 is linked to metabolic dysfunction-associated steatotic liver disease.